Grundinformationen
- Standard-SMILES
CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1- InChIKey
VSJKWCGYPAHWDS-FQEVSTJZSA-N- Summenformel
- C20H16N2O4
- Durchschnittliche Molmasse
- 348,4 g/mol
- Monoisotopische Masse
- 348,11100699
Überblick
Camptothecin is a pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer). It has a role as an antineoplastic agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a genotoxin and a plant metabolite. It is a delta-lactone, a quinoline alkaloid, a tertiary alcohol and a pyranoindolizinoquinoline.
Namen und Bezeichner
- Bevorzugter Name
- Camptothecin
- IUPAC
- (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione
- Englischer Name
- (+)-Camptothecin
- Summenformel
- C20H16N2O4
- Molmasse
- 348.35
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
7689-03-4- PubChem CID
- 24360
- DTXSID
DTXSID0030956- ChEMBL
CHEMBL65- ChEBI
CHEBI:27656- UNII
- XT3Z54Z28A
- EC Number
- 444-280-6、616-407-7
- Nikkaji
- J2.266G
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1
- Polarare Oberfläche (TPSA)
- 79,7 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 5
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 26
- Formalladung
- 0
- Komplexität
- 742
Experimentelle und physikochemische Eigenschaften
Drugs
Pharmaceuticals -> Listed in ZINC15
Pharmaceuticals -> Antibiotics
Collision Cross Section
178.35 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
181.9 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
Physikochemische Eigenschaften
- Schmelzpunkt
- 260 °C · 260 °C (dec.)(lit.)
- Siedepunkt
- 482.73 °C · 482.73°C (rough estimate)
- Dichte
- 1.3112 · 1.3112 (rough estimate)
- Brechungsindex
- 1.57 · 1.5700 (estimate)
- storage temp.
- 2 · 2-8°C
- Löslichkeit
- 4 · chloroform/methanol (4:1): 4 mg/mL
- Aggregatzustand
- solid
- pka
- 10.83 · pKa 10.83 (Uncertain)
- Farbe
- yellow
- Wasserlöslichkeit
- insoluble
- Merck
- 14 · 14,1735
- BRN
- 631069 · 631069
- Stabilität
- 1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
- InChI
- 1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1
- InChIKey
- VSJKWCGYPAHWDS-FQEVSTJZSA-N
- SMILES
- CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5ccccc5nc34)C2=O
- LogP
- 1.74 · 1.740
- CAS Datenbank
- 7689 · 7689-03-4(CAS DataBase Reference)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Danger
H301 (98%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P264, P270, P280, P301+P316, P318, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 50 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Danger
H301 (97.1%): Toxic if swallowed [Danger Acute toxicity, oral]
Gefahrenhinweise
Hazard Classes and Categories
Acute Tox. 3 (98%)
Acute Tox. 3 (97.1%)
Sicherheitsdaten
- wgk
- 3
- ridadr
- UN 1544 6.1/PG 3
- hs_code
- 29399990
- RTECS-Nr.
- UQ0492000
- risk_code
- 36/37/38-25-20/21/22
- hazard_code
- T,Xi,Xn
- hazard_note
- Irritant
- safety_code
- 45-36/37/39-26-36
- hazard_class
- 6.1
- packing_group
- Ⅲ
- Speicherklasse
- 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- Hazard Classifications
- Acute Tox. 3 OralMuta. 1B
Chemie und Industrie
Pharmakologische Informationen
Pharmacodynamics
Camptothecin demonstrated strong anticancer activity in preliminary clinical trials but also low solubility and adverse drug reaction. Camptothecin is believed to be a potent topoisomerase inhibitor that interferes with the essential function of topoisomerase in DNA replication.
MeSH Pharmacological Classification
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.
Compounds that inhibit the activity of DNA TOPOISOMERASE I.
Anwendungen
BeschreibungCamptothecin is an alkaloid derived from Xi Shu (Camptotheca acuminata), which belongs to Nyssaceae. The traditional Chinese medicine Camptotheca acuminata (Xi Shu) has been collected in the Compilation of Chinese Herbal Medicine, Chinese Materia Medica, and Great Dictionary of Chinese Medicine. Camptotheca acuminata (Xi Shu) is widely distributed in the basin of Yangtze river and the southwestern provinces. The main medicinal parts of Camptotheca acuminata (Xi Shu) are root bark and fruit, which get rid of heat and toxic materials and eliminate the disease.
HistoryIn 1966, Wall M E et al. from the United States isolated an alkaloid from Camptotheca acuminata and defined its chemical structure. The invitro anticancer tests revealed the anticancer activity of the tryptophan-terpene alkaloid, which is known as camptothecin and received widely concern. In 1975, Corey etal. first opened the door for the chiral synthesis of camptothecin, but the reaction step was long and the yield rate was very low. It was not until 1997 that Ciufolini etal. developed a new method for the synthesis of camptothecin by five steps, with a total yield rate up to 51%. The great breakthrough in the chemical synthesis of camptothecin has made its extensive application become a reality.Hydroxycamptothecin, as a camptothecin derivative with a hydroxyl group on the tenth carbon atom, is widely used for the treatment of various cancers. In 1969, researchers from Shanghai Institute of Materia Medica found that hydroxycamptothecin possessed potent anticancer activity and low toxicity. And this finding promoted the production and clinical application of hydroxycamptothecin, but its usage was interrupted for technology and quality. In the 1980s, hydroxycamptothecin was reproduced for clinical application with an improvement in producing technology, and hydroxycamptothecin got its approval number in 1986 for clinical usage in China. In the 1990s, the US Food and Drug Administration approved the clinical application of topotecan and irinotecan, which played a significant role in the prevention and treatment of cancers.
VerwendenAntitumor alkaloid. Binds irreversible to the DNA-topoisomerase I complex, inhibiting the reassociation of DNA after cleavage by topoisomerase I and traps the enzyme in a covalent linkage with DNA. A cytotoxic antitumor agent
Vor- und nachgelagerte Produkte
Vorgelagerte Rohstoffe
Nachgelagerte Produkte
Anbieter50 Anbieter
Ergänzende Hinweise
DefinitionChEBI: A pyranoindolizinoquinoline that is pyrano[3',4':6,7]indolizino[1,2-b]quinoline which is substituted by oxo groups at positions 3 and 14, and by an ethyl group and a hydroxy group at position 4 (the S enantiomer).
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…